Table 3 Systematic review of the results of the studies assessing preventive treatment for POI.
First author | Unity | Time to FF (ref) | Time to FF (exp) | Time to FBM (ref) | Time to FBM (exp) | POI (%) (ref) | POI (%) (exp) |
|---|---|---|---|---|---|---|---|
Lim et al.44 | 50.97 ± 3.79 | 42.75 ± 3.92 | 98.61 ± 7.06 | 89.64 ± 5.94 | – | – | |
Zaghyian et al.43 | Hours | 47.4 (29.4) | 48.6 (33.4) | 63.2 (41.9) | 56.9 (37.8) | 6.6% | 7.4% |
Byrne et al.42 | Hours | 58.0 (42.0–74.0 | 42.0 (36.4–47.6) | 80.0, 67.2–92.8 | 50.0, 45.2–54.8 | 17% | 10% |
Shum et al.40 | Hours | 34 (7–144) | 18 (5–90) | 44 (9–152) | 19 (5–81) | – | – |
Yang et al.41 | Hours | 64.1 (24.8–71.3) | 62.3 (21.4–70.5) (CG) | 75.2 (29.0–241.6) | 119.3 (31.5–211.4) CG) | – | – |
Atkinson et al.45 | Days | 2 (1–3) | 2 (2–3) | 3 (1–4) | 2 (1–3) | 14.1% | 9.4% |
Itawi et al.35 | – | – | – | – | 20% | 2% | |
Ludwig et al.34 | – | – | – | – | - | - | |
Barletta et al.37 | – | – | – | – | 21.7% | 16.4% | |
Obokhare et al.33 | – | – | – | – | 12% | 4% | |
Wen et al.38 | – | – | – | – | 10.3% | 3.4% | |
Adam et al.36 | – | – | – | – | 16% | 5% | |
Hyde et al.32 | – | – | – | – | 16.2% | 10.8% | |
Keller et al.39 | – | – | – | – | 2.2% | 2.2% | |
Müller et al.46 | Hours | 46.4 (20.1) | 40.6 (16.1) | 74.0 (21.6) | 60.4 (21.3) | – | – |
Hasler-Gehrer et al.47 | Hours | 31 (25–46) | 40 (29–52) | 74.1 (60.7–87.5) | 65.2 (50.5–79.8) | – | – |
Dulskas et al.48 | Days | 1.57 | 1.77 (Coffee) | 4.14 (± 1.15) | 3.75 (± 1.53) | – | – |
Springer et al.53 | Hours | 37.9 ± 23.9 | 37.6 ± 26.7 | 41.1 ± 28.2 | 42.1 ± 25.2 | 4.7% | 3.5% |
Danelich et al.56 | – | – | 31.8 (22.5–54.4) | 52.9 (45.3–82.4) | 15.7% | 20.5% | |
Andersen et al.51 | 14.0 (6–46) | 18.0 (6–62) | 50.0 (6–70) | 42.0 (14–110) | – | – | |
Raju et al.55 | – | – | – | – | 13.4% | 7.23% | |
Lohsiriwat et al.54 | – | – | 3 (3–4) | 2 (2–3) | 8% | 5% | |
Singh et al.57 | 1 (1–3) | 2 (1–2) | 4 (1–5) | 4 (2–7) | 22% | 18% | |
Gong et al.52 | 73.0 (7–305) | 51.0 (26–129) | 94.5 (27–315) | 64.0 (25–172) | 35.7% | 17.8% | |
Popescu et al.49 | 2.85 _2.31, 2.93_ | 2.20 _1.92, 2.80_ | – | – | 0 | 4.2% | |
Falken et al.50 | days | 3.5 (± 0.4) | 2.1 (± 3) | – | – | – | – |
Venara et al.59 | days | 2.16 ± 0.32 | 1.47 ± 0.19 | – | – | 42% | 6.1% |